BIOTHERA LIFESCIENCES Trademark

Trademark Overview


On Monday, August 25, 2025, a trademark application was filed for BIOTHERA LIFESCIENCES with the United States Patent and Trademark Office. The USPTO has given the BIOTHERA LIFESCIENCES trademark a serial number of 99356391. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, January 14, 2026. This trademark is owned by Biothera LifeSciences LLC. The BIOTHERA LIFESCIENCES trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consultancy services; Business intermediary services relating to the matching of various professionals with clients; Providing consumer news and information in the field of educational products and services that help individuals and businesses make and save money; Manufacturer representatives in the field of modular cleanrooms and controlled-environment manufacturing facilities for the pharmaceutical, biotechnology, cell and gene therapy, microelectronics, semiconductor, compounding pharmacy, pharmaceutical raw materials, active pharmaceutical ingredients (APIs), and laboratory industries; validation, compliance, and quality assurance services.; Independent sales representatives in the field of Cleanrooms and controlled-environment manufacturing facilities, including engineering design, technical consultancy, architectural and manufacturing services, for the pharmaceutical, biotechnology, cell and gene therapy, microelectronics, semiconductor, compounding pharmacy, active phar...
biothera lifesciences

General Information


Serial Number99356391
Word MarkBIOTHERA LIFESCIENCES
Filing DateMonday, August 25, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, January 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIOTHERA LIFE SCIENCES
Goods and ServicesBusiness consultancy services; Business intermediary services relating to the matching of various professionals with clients; Providing consumer news and information in the field of educational products and services that help individuals and businesses make and save money; Manufacturer representatives in the field of modular cleanrooms and controlled-environment manufacturing facilities for the pharmaceutical, biotechnology, cell and gene therapy, microelectronics, semiconductor, compounding pharmacy, pharmaceutical raw materials, active pharmaceutical ingredients (APIs), and laboratory industries; validation, compliance, and quality assurance services.; Independent sales representatives in the field of Cleanrooms and controlled-environment manufacturing facilities, including engineering design, technical consultancy, architectural and manufacturing services, for the pharmaceutical, biotechnology, cell and gene therapy, microelectronics, semiconductor, compounding pharmacy, active pharmaceutical ingredients (APIs), and laboratory industries; validation, compliance, and quality assurance services; Sales promotion services for third parties

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, August 25, 2025
Primary Code035
First Use Anywhere DateThursday, March 20, 2025
First Use In Commerce DateThursday, March 20, 2025

Trademark Owner History


Party NameBiothera LifeSciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKATY, TX 77494

Trademark Events


Event DateEvent Description
Monday, August 25, 2025NEW APPLICATION ENTERED
Monday, August 25, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, January 13, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 14, 2026ASSIGNED TO EXAMINER
Wednesday, January 14, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 14, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 14, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED